Of the six individuals who received CAR T-cells after blinatumomab, three were alive in CR at last follow-up, two initially responded to blinatumomab and died after relapse, and one received CAR T-cells like a non-responder to blinatumomab and died after CAR T-cell treatment 3 min read Motilin Receptor Of the six individuals who received CAR T-cells after blinatumomab, three were alive in CR at last follow-up, two initially responded to blinatumomab and died after relapse, and one received CAR T-cells like a non-responder to blinatumomab and died after CAR T-cell treatment cmerp September 28, 2024 Of the six individuals who received CAR T-cells after blinatumomab, three were alive in CR at last...Read More